Isabel Jakobs has many years of experience in product regulatory advice as well as in product liability law. She places a particular focus on the Life Sciences & HealthCare industry. She combines in-depth industry knowledge with strategic legal expertise to guide her clients through complex and constantly evolving regulatory frameworks. Her main area of practice lies in advising pharmaceutical and medical device companies, hospitals, biotechnology firms, as well as chemical and tobacco corporations. She provides particular support on challenging issues relating to market access strategies, digitalization in healthcare, product regulation, M&A transactions, as well as product-related environmental and social security law. In addition, Isabel Jakobs also regularly advises clients from various other industries on questions of product compliance. She is the author of numerous publications and serves as an advisory board member for the journal “Medizinprodukte Journal” (MPJ). She also regularly lectures on quality management at the University of Kassel (Germany) and gives presentations on product regulatory topics at various industry events.

Distinctions

  • Recommended for Dispute Resolution/Product Liability and Health by Legal 500 (2022/2023).

Career

Studied law at Ludwig Maximilian University in Munich
Traineeship under the remit of Munich Higher Regional Court, including a seat at a leading international commercial law firm in Paris
Doctorate (Dr. jur.) at Augsburg University
Experience as a lawyer with an international law firm in Munich with a focus on life sciences
At Noerr since 2019
Admitted to the Munich Chamber of Lawyers

Lectures

  • "Quality and Law"; regular guest lecture at the University of Kassel

Publications

  • Germany - Liability for Medicinal Products and the Right to Disclosure under German Law" (co-author, in European Pharmaceutical Law Review 2/2018)
  • Comment on a decision of Kammergericht Berlin, ruling of 23 May 2016, 20 U 207/15 (co-author, in MPR 2/2018)
  • Betreiberspezifische Aspekte der neuen Europäischen Medizinprodukteverordnung (co-author, in GuP 2017)
  • Rückruf fehlerhafter Medizinprodukte bei deliktischer Produkthaftung, Dissertationsschrift (PhD thesis), published in „Augsburger Schriften zum Arzneimittel und Medizinprodukterecht"
  • Software als Medizinprodukt: Haftungs- und versicherungsrechtliche Aspekte (co-author, in MPR 1/2019)
  • Messverfahren von Emissionshöchstwerten bei Zigaretten und Zulässigkeit des Verweises auf (private) ISO-Normen“ (comment on ECJ ruling, February 22, 2022 - C-160/20; in ZfPC 3/2022).
  • Doctor A.I.: Künstliche Intelligenz und Medizinprodukte, (in Robotik und Produktion, 21 April 2022)
  • Poland: Advertising Medical Devices – The New European and Polish Regulatory Framework (co-author, in CEE Legal Matters, 7 February 2023)

Well
informed

Subscribe to our newsletter now to stay up to date on the latest developments.

Subscribe now